triazoles has been researched along with AIDS-Related Opportunistic Infections in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (17.86) | 18.2507 |
2000's | 33 (58.93) | 29.6817 |
2010's | 13 (23.21) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bordin-Wosk, T; Chun, V; Dhamija, A; Kadakia, A; Lin, AY | 1 |
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK | 1 |
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
Camacho, A; Genebat, M; Leal, M; Rivero, A | 1 |
Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M | 1 |
Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P | 1 |
Aiuti, F; Esposito, A; Fantauzzi, A; Isgro, A; Leti, W; Mezzaroma, I; Pastori, D | 1 |
Alvarez, M; Cuvinciuc, V; Cuzin, L; Delobel, P; Dumas, H; Marchou, B; Martin-Blondel, G; Massip, P | 1 |
Cleveland, KO; Mazumder, SA; Norwood, J | 1 |
Baietto, L; Bertucci, R; Calcagno, A; D'Avolio, A; De Rosa, FG; Di Perri, G; Libanore, V; Tettoni, MC | 1 |
Nweze, EI; Ogbonnaya, UL | 1 |
Fulco, PP; Gibson, JN | 1 |
Cui, Y; Jin, C; Li, X; Wu, N | 1 |
Bustos Terol, S; Cama-Barbieri, J; Caro-Martínez, E; Reus-Bañuls, S | 1 |
Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
Flores, VG; Martinez, EA; Tovar, RM; Zaldivar, PG | 1 |
Lu, HZ; Shen, YZ; Wang, ZY | 1 |
Abdulaziz, S; Al Jahdali, H; Baharoon, S | 1 |
Greenberg, RN; Martin, CA; Roberts, S | 1 |
Albougy, HA; Naidoo, S | 1 |
Brown, N; Chau, AS; DiDomenico, B; Hare, RS; Li, X; Loebenberg, D; López-Ribot, JL; McNicholas, PM; Mendrick, CA; Quindos, G; Ruesga, MT | 1 |
Barchiesi, F; Carle, F; Giannini, D; Maracci, M; Scalise, G; Schimizzi, AM; Spreghini, E | 1 |
Clezy, K; van Hal, SJ | 1 |
Al-Agha, OM; Mooty, M; Salarieh, A | 1 |
Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA | 1 |
Klotz, SA | 1 |
Brizendine, E; Connolly, P; Durkin, M; Goldman, M; Mann, P; McNicholas, PM; Patel, R; Smedema, M; Wheat, LJ | 1 |
Jarque, I; Salavert, M | 1 |
Cepero de García, MC; Espinel-Ingroff, A; Rincón, S | 1 |
Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM | 1 |
Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D | 1 |
Kalavsky, E; Krcmery, V; Liskova, A; Shahum, A | 1 |
Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB | 1 |
Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C | 1 |
Winslow, DL | 1 |
Schlamm, HT; Supparatpinyo, K | 1 |
Fung, HB; Schiller, DS | 1 |
Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT | 1 |
Givner, LB; Horn, CA; Peacock, JE; Pegram, PS; Washburn, RG | 1 |
Dismukes, WE | 1 |
Barchiesi, F; Colombo, AL; Fothergill, AW; McGough, DA; Rinaldi, MG | 1 |
Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA | 1 |
Gubbins, PO; Penzak, SR | 1 |
Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA; Midgley, J | 1 |
Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Atkinson, G; Denning, DW; Hollis, S; Hood, SV; Percy, M; Williams, K | 1 |
Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A | 1 |
Ernst, EJ; Hoffman, HL; Klepser, ME | 1 |
Müller, FM; Weig, M | 1 |
Ellepola, AN; Samaranayake, LP | 2 |
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
Colebunders, R; Ieven, M; Noë, A; Ostyn, B; Swinne, D | 1 |
11 review(s) available for triazoles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole | 2014 |
[At what time and with which combinations should maraviroc be indicated in the new antiretroviral treatment scenario?].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclohexanes; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; HIV; HIV Infections; Humans; Maraviroc; Membrane Fusion; Receptors, CXCR4; Salvage Therapy; Triazoles; Viral Load; Virus Attachment | 2008 |
A systematic review of the management of oral candidiasis associated with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Comorbidity; HIV Infections; Humans; Practice Guidelines as Topic; Treatment Outcome; Triazoles | 2002 |
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Posaconazole: an extended-spectrum triazole antifungal agent.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles | 2007 |
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Management of cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Meningitis; Triazoles | 1993 |
Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Triazoles | 1998 |
Novel triazole antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles | 2000 |
Antimycotic agents in oral candidosis: an overview: 1. Clinical variants.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Cheilitis; Drug Resistance, Microbial; Glossitis; Humans; Immunocompromised Host; Opportunistic Infections; Stomatitis, Denture; Treatment Outcome; Triazoles | 2000 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
5 trial(s) available for triazoles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidiasis, Oral; Double-Blind Method; Ethnicity; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pharyngeal Diseases; Probability; Treatment Outcome; Triazoles | 2006 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles | 2007 |
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Recurrence; Treatment Outcome; Triazoles | 1997 |
Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome; Triazoles | 1998 |
Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome; Triazoles | 1999 |
40 other study(ies) available for triazoles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Immune reconstitution inflammatory syndrome in an HIV-infected patient with disseminated coccidioidomycosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Coccidioidomycosis; Fluconazole; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Prednisone; Treatment Outcome; Triazoles | 2019 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Immunorecovery after prolonged HIV-related immunosuppression: opportunities of the new antiretroviral classes].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclohexanes; Darunavir; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunocompetence; Interleukin-2; Male; Maraviroc; Middle Aged; Reverse Transcriptase Inhibitors; Sulfonamides; T-Lymphocyte Subsets; Triazoles; Viral Load | 2009 |
Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Cyclohexanes; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Maraviroc; Triazoles | 2009 |
Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Itraconazole; Lung; Mycetoma; Pneumothorax; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.
Topics: Africa, Western; AIDS-Related Opportunistic Infections; Antifungal Agents; Brain; CD4 Lymphocyte Count; Central Nervous System Fungal Infections; Cerebrospinal Fluid; HIV Infections; Humans; Inhibitory Concentration 50; Magnetic Resonance Imaging; Mucormycosis; Radiography; Triazoles | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; Drug Resistance, Multiple, Viral; Humans; Male; Middle Aged; Mycetoma; Oligopeptides; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult | 2011 |
[Cerebral aspergillosis in an human immunodeficiency virus infected patient].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Brain Edema; Cytomegalovirus Infections; Female; HIV Infections; Humans; Magnetic Resonance Imaging; Morocco; Neuroaspergillosis; Serratia Infections; Toxoplasmosis, Cerebral; Triazoles | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Meningitis due to Cryptococcus neoformans: treatment with posaconazole.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Humans; Male; Meningitis, Cryptococcal; Mexico; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2012 |
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Combination antifungal therapy for invasive pulmonary aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Genes, Viral; HIV Infections; Humans; Microbial Sensitivity Tests; Mutation; Triazoles | 2004 |
Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Progression; Drug Therapy, Combination; Humans; Lung; Male; Mice; Survival Analysis; Triazoles | 2004 |
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Bone Marrow; Female; Fever of Unknown Origin; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Pyrimidines; Silver Staining; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Oropharyngeal candidiasis: a new treatment option.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Humans; Pharyngeal Diseases; Triazoles | 2006 |
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amino Acid Substitution; Antifungal Agents; Binding Sites; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Mutation; Triazoles | 2006 |
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis | 2006 |
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infections; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Polysorbates; Pyrimidines; Triazoles; Urea; Voriconazole | 2006 |
Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cambodia; Candida; Candidiasis, Oral; Child; Drug Resistance, Multiple, Fungal; Humans; Oropharynx; Pharyngeal Diseases; Pyrimidines; Saccharomyces; Triazoles; Voriconazole | 2007 |
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole | 2007 |
Posaconazole for azole-refractory candidiasis in patients with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Administration Schedule; Esophageal Diseases; Humans; Mouth Diseases; Pharyngeal Diseases; Triazoles | 2007 |
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole | 2007 |
Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candidiasis; Candidiasis, Oral; Child, Preschool; Drug Resistance, Microbial; Esophageal Diseases; Female; Humans; Male; Middle Aged; Triazoles | 1995 |
In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Stereoisomerism; Triazoles | 1994 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 1999 |
Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Synergism; HIV Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Pharyngitis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
A multidrug, including voriconazole, resistant oral Candida infection in an AIDS patient effectively treated with echinocandin.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Male; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |